Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wesail Biotech is a Chinese high-tech company specializing in the research & development and manufacturing of in vitro diagnostic reagents and analyzers. Their product portfolio includes rapid test kits based on immunofluorescence and colloidal gold technology for point-of-care testing across multiple disease areas. The company gained international recognition during the COVID‑19 pandemic with its SARS-CoV‑2 test kits entering global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wesail Biotech.